311 related articles for article (PubMed ID: 23252742)
1. Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.
Weerts EM; Wand GS; Kuwabara H; Xu X; Frost JJ; Wong DF; McCaul ME
Addict Biol; 2014 Jul; 19(4):733-42. PubMed ID: 23252742
[TBL] [Abstract][Full Text] [Related]
2. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
Nuechterlein EB; Ni L; Domino EF; Zubieta JK
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.
Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME
Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118
[TBL] [Abstract][Full Text] [Related]
4. Tobacco Smoking and Brain Endogenous Opioid Release: More Than Nicotine Alone.
Domino EF; Hirasawa-Fujita M
Nicotine Tob Res; 2019 May; 21(6):772-777. PubMed ID: 29514324
[TBL] [Abstract][Full Text] [Related]
5. The Kappa Opioid Receptor Is Associated With Naltrexone-Induced Reduction of Drinking and Craving.
de Laat B; Goldberg A; Shi J; Tetrault JM; Nabulsi N; Zheng MQ; Najafzadeh S; Gao H; Kapinos M; Ropchan J; O'Malley SS; Huang Y; Morris ED; Krishnan-Sarin S
Biol Psychiatry; 2019 Dec; 86(11):864-871. PubMed ID: 31399255
[TBL] [Abstract][Full Text] [Related]
6. Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects.
Weerts EM; Kim YK; Wand GS; Dannals RF; Lee JS; Frost JJ; McCaul ME
Neuropsychopharmacology; 2008 Feb; 33(3):653-65. PubMed ID: 17487229
[TBL] [Abstract][Full Text] [Related]
7. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis.
Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC
Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425
[TBL] [Abstract][Full Text] [Related]
8. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil.
Heinz A; Reimold M; Wrase J; Hermann D; Croissant B; Mundle G; Dohmen BM; Braus DF; Schumann G; Machulla HJ; Bares R; Mann K
Arch Gen Psychiatry; 2005 Jan; 62(1):57-64. PubMed ID: 15630073
[TBL] [Abstract][Full Text] [Related]
9. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
[TBL] [Abstract][Full Text] [Related]
10. Regional brain activity correlates of nicotine dependence.
Rose JE; Behm FM; Salley AN; Bates JE; Coleman RE; Hawk TC; Turkington TG
Neuropsychopharmacology; 2007 Dec; 32(12):2441-52. PubMed ID: 17356570
[TBL] [Abstract][Full Text] [Related]
11. Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers.
Kuwabara H; Heishman SJ; Brasic JR; Contoreggi C; Cascella N; Mackowick KM; Taylor R; Rousset O; Willis W; Huestis MA; Concheiro M; Wand G; Wong DF; Volkow ND
PLoS One; 2014; 9(12):e113694. PubMed ID: 25493427
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
Jones JD; Babalonis S; Marcus R; Vince B; Kelsh D; Lofwall MR; Fraser H; Paterson B; Martinez S; Martinez DM; Nunes EV; Walsh SL; Comer SD
Addict Biol; 2020 Jul; 25(4):e12799. PubMed ID: 31240842
[TBL] [Abstract][Full Text] [Related]
13. The Relationship of Varenicline Agonism of α4β2 Nicotinic Acetylcholine Receptors and Nicotine-Induced Dopamine Release in Nicotine-Dependent Humans.
McCaul ME; Wand GS; Kuwabara H; Dannals RF; Wong D; Xu X
Nicotine Tob Res; 2020 May; 22(6):892-899. PubMed ID: 31096265
[TBL] [Abstract][Full Text] [Related]
14. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
Wand GS; Weerts EM; Kuwabara H; Wong DF; Xu X; McCaul ME
Addict Biol; 2013 Jan; 18(1):181-92. PubMed ID: 22264217
[TBL] [Abstract][Full Text] [Related]
15. Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence.
Bencherif B; Wand GS; McCaul ME; Kim YK; Ilgin N; Dannals RF; Frost JJ
Biol Psychiatry; 2004 Feb; 55(3):255-62. PubMed ID: 14744466
[TBL] [Abstract][Full Text] [Related]
16. Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse.
Fehr C; Yakushev I; Hohmann N; Buchholz HG; Landvogt C; Deckers H; Eberhardt A; Kläger M; Smolka MN; Scheurich A; Dielentheis T; Schmidt LG; Rösch F; Bartenstein P; Gründer G; Schreckenberger M
Am J Psychiatry; 2008 Apr; 165(4):507-14. PubMed ID: 18316420
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone alteration of acute smoking response in nicotine-dependent subjects.
King AC; Meyer PJ
Pharmacol Biochem Behav; 2000 Jul; 66(3):563-72. PubMed ID: 10899371
[TBL] [Abstract][Full Text] [Related]
18. Regional brain [(11)C]carfentanil binding following tobacco smoking.
Domino EF; Hirasawa-Fujita M; Ni L; Guthrie SK; Zubieta JK
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():100-104. PubMed ID: 25598501
[TBL] [Abstract][Full Text] [Related]
19. Smoking history, nicotine dependence, and changes in craving and mood during short-term smoking abstinence in alcohol dependent vs. control smokers.
Heffner JL; Mingione C; Blom TJ; Anthenelli RM
Addict Behav; 2011 Mar; 36(3):244-7. PubMed ID: 21106299
[TBL] [Abstract][Full Text] [Related]
20. Nicotine and Nicotine Abstinence Do Not Interfere with GABAA Receptor Neuroadaptations During Alcohol Abstinence.
Hillmer AT; Kloczynski T; Sandiego CM; Pittman B; Anderson JM; Labaree D; Gao H; Huang Y; Deluliis G; O'Malley SS; Carson RE; Cosgrove KP
Alcohol Clin Exp Res; 2016 Apr; 40(4):698-705. PubMed ID: 26971694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
